Insider Selling: UnitedHealth Group Inc (UNH) Director Sells 5,000 Shares of Stock

Share on StockTwits

UnitedHealth Group Inc (NYSE:UNH) Director Richard T. Burke sold 5,000 shares of the firm’s stock in a transaction dated Tuesday, March 12th. The stock was sold at an average price of $245.01, for a total value of $1,225,050.00. Following the sale, the director now directly owns 182,372 shares of the company’s stock, valued at $44,682,963.72. The transaction was disclosed in a document filed with the SEC, which is available through this link.

Shares of UNH stock traded up $1.02 during trading on Thursday, reaching $253.27. The company had a trading volume of 3,781,063 shares, compared to its average volume of 4,301,155. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.73 and a current ratio of 0.73. UnitedHealth Group Inc has a one year low of $212.49 and a one year high of $287.94. The company has a market capitalization of $235.93 billion, a price-to-earnings ratio of 19.66, a PEG ratio of 1.26 and a beta of 0.79.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, January 15th. The healthcare conglomerate reported $3.28 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.20 by $0.08. UnitedHealth Group had a return on equity of 24.38% and a net margin of 5.30%. The business had revenue of $58.42 billion for the quarter, compared to the consensus estimate of $58.01 billion. During the same period last year, the business earned $2.59 EPS. The firm’s revenue was up 12.2% compared to the same quarter last year. On average, analysts forecast that UnitedHealth Group Inc will post 14.62 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th will be given a $0.90 dividend. This represents a $3.60 annualized dividend and a yield of 1.42%. The ex-dividend date is Friday, March 8th. UnitedHealth Group’s dividend payout ratio is currently 27.95%.

A number of hedge funds and other institutional investors have recently modified their holdings of UNH. Bbva Compass Bancshares Inc. increased its position in UnitedHealth Group by 3.1% in the 3rd quarter. Bbva Compass Bancshares Inc. now owns 26,255 shares of the healthcare conglomerate’s stock worth $6,985,000 after buying an additional 793 shares during the period. Oakwood Capital Management LLC CA bought a new position in UnitedHealth Group in the 3rd quarter worth approximately $5,508,000. First Long Island Investors LLC increased its position in UnitedHealth Group by 2.2% in the 3rd quarter. First Long Island Investors LLC now owns 25,443 shares of the healthcare conglomerate’s stock worth $6,769,000 after buying an additional 548 shares during the period. Buckingham Asset Management LLC grew its holdings in shares of UnitedHealth Group by 19.3% during the 3rd quarter. Buckingham Asset Management LLC now owns 17,896 shares of the healthcare conglomerate’s stock worth $4,761,000 after purchasing an additional 2,894 shares in the last quarter. Finally, Foyston Gordon & Payne Inc grew its holdings in shares of UnitedHealth Group by 7.9% during the 3rd quarter. Foyston Gordon & Payne Inc now owns 80,948 shares of the healthcare conglomerate’s stock worth $21,535,000 after purchasing an additional 5,926 shares in the last quarter. 85.80% of the stock is currently owned by institutional investors.

A number of equities research analysts have recently weighed in on UNH shares. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research note on Wednesday, November 21st. Cantor Fitzgerald reaffirmed a “buy” rating and set a $310.00 price target on shares of UnitedHealth Group in a research note on Wednesday, November 21st. BMO Capital Markets set a $310.00 price target on UnitedHealth Group and gave the stock a “buy” rating in a research note on Tuesday, November 27th. Piper Jaffray Companies raised their price target on UnitedHealth Group to $312.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 28th. Finally, Oppenheimer raised their price target on UnitedHealth Group from $295.00 to $300.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 28th. Two analysts have rated the stock with a hold rating and twenty-one have assigned a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $297.80.

WARNING: This article was originally posted by Week Herald and is the sole property of of Week Herald. If you are accessing this article on another publication, it was copied illegally and reposted in violation of US and international copyright & trademark laws. The correct version of this article can be viewed at https://weekherald.com/2019/03/14/insider-selling-unitedhealth-group-inc-unh-director-sells-5000-shares-of-stock.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Featured Story: What is the S&P 500 Index?

Insider Buying and Selling by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.